Institute of Hypertension, Sun Yat-sen University School of Medicine , Guangzhou , China.
Department of Internal Medicine, University of Utah School of Medicine and Veterans Affairs Medical Center , Salt Lake City, Utah.
Am J Physiol Cell Physiol. 2017 Dec 1;313(6):C632-C643. doi: 10.1152/ajpcell.00006.2017. Epub 2017 Sep 13.
Proteinuria is a characteristic of chronic kidney disease and also a causative factor that promotes the disease progression, in part, via activation of the intrarenal renin-angiotensin system (RAS). (Pro)renin receptor (PRR), a newly discovered component of the RAS, binds renin and (pro)renin to promote angiotensin I generation. The present study was performed to test the role of soluble PRR (sPRR) in albumin overload-induced responses in cultured human renal proximal tubular cell line human kidney 2 (HK-2) cells. Bovine serum albmuin (BSA) treatment for 24 h at 20 mg/ml induced renin activity and inflammation, both of which were attenuated by a PRR decoy inhibitor PRO20. BSA treatment induced a more than fivefold increase in medium sPRR due to enhanced cleavage of PRR. Surprisingly, this cleavage event was unaffected by inhibition of furin or a disintegrin and metalloproteinase 19. Screening for a novel cleavage enzyme led to the identification of site-1 protease (S1P). Inhibition of S1P with PF-429242 or siRNA remarkably suppressed BSA-induced sPRR production, renin activity, and inflammatory response. Administration of a recombinant sPRR, termed sPRR-His, reversed the effects of S1P inhibition. In HK-2 cells overexpressing PRR, mutagenesis of the S1P, but not furin cleavage site, reduced sPRR levels. Together, these results suggest that PRR mediates albumin-induced cellular responses through S1P-derived sPRR.
蛋白尿是慢性肾脏病的特征,也是促进疾病进展的一个致病因素,部分原因是通过激活肾内肾素-血管紧张素系统(RAS)。(前)肾素受体(PRR),是 RAS 的一个新发现的组成部分,它结合肾素和(前)肾素来促进血管紧张素 I 的产生。本研究旨在检测可溶性 PRR(sPRR)在培养的人肾近端肾小管细胞系人肾 2(HK-2)细胞中白蛋白过载诱导反应中的作用。20mg/ml 的牛血清白蛋白(BSA)处理 24 小时诱导肾素活性和炎症,两者均被 PRR 诱饵抑制剂 PRO20 减弱。BSA 处理导致介质 sPRR 增加五倍以上,这是由于 PRR 的切割增强所致。令人惊讶的是,这种切割事件不受 furin 或解整合素金属蛋白酶 19 的抑制影响。筛选新的切割酶导致鉴定出位点 1 蛋白酶(S1P)。用 PF-429242 或 siRNA 抑制 S1P 可显著抑制 BSA 诱导的 sPRR 产生、肾素活性和炎症反应。给予重组 sPRR,称为 sPRR-His,可逆转 S1P 抑制的作用。在过表达 PRR 的 HK-2 细胞中,S1P 而不是 furin 切割位点的突变降低了 sPRR 水平。总之,这些结果表明 PRR 通过 S1P 衍生的 sPRR 介导白蛋白诱导的细胞反应。